Source: Opus and Circle Health, October 15, 2026 announcement
In behavioral health, the hardest part of getting paid is often proving why care needed to continue. A patient may receive medically appropriate treatment, yet reimbursement can depend on fragmented assessments, progress notes, treatment plans, utilization-review records and insurer requirements. Opus and Circle Health are partnering to connect those pieces—and turn clinical evidence into action before reimbursement problems become denials or write-offs.
On October 15, Opus and Circle Health announced an active go-to-market partnership. Opus provides an EHR, CRM and RCM platform for behavioral health and substance use disorder treatment providers. Circle offers an AI-powered layer designed to connect and normalize information across clinical records, billing systems, payer contracts and business applications, then support documentation review, prior authorizations, appeals, audit readiness and revenue recovery.
The partnership is commercially active today: Opus sales, onboarding, customer success and revenue-cycle teams are equipped to identify client needs and introduce Circle. However, the companies say they are still exploring deeper technical and workflow integrations. The announcement should not be read as evidence that every Circle action is already natively embedded inside every Opus deployment.
Opus reports a behavioral health RCM team's authorized-day improvement using Circle and a separate clinic's rapid review of a payer prepayment audit. These are company-reported examples without disclosed study design, cohort, adjustment for case mix or independently verified cash impact. They are not guaranteed outcomes across the partnership.
Behavioral health revenue cycle is unusually intertwined with medical necessity. A program can document that treatment occurred, yet still face a dispute over the appropriate level of care, continued-stay criteria, authorization period or progress toward treatment goals.
Care plans, assessments and progress notes may contain most of the evidence needed to support reimbursement, but the relevant facts can be spread across dozens of entries and stored in systems that were not designed to communicate with one another. Staff then reconstruct the narrative manually for utilization review, payer requests and appeals.
That makes the problem different from claim scrubbing alone. A technically valid claim may fail because the payer's continuing-care criteria were not documented clearly, the authorized days have expired, or the clinical rationale was not assembled in a usable form.
Opus's strategy is to provide the core operating environment for treatment centers. Circle is positioned to assemble the context around clinical and financial activity, identify gaps and prepare the next authorized action.
The valuable layer in behavioral health RCM may be the one that continuously connects treatment evidence to payer rules and financial outcomes. Drafting an appeal is one task. Knowing what the record actually supports, fixing omissions and preventing the next coverage interruption can be far more valuable.
Many analytical products can tell a provider that denials have risen or that collections are below expectations. A more ambitious system must show why a particular payer, service line or facility is underperforming and provide a controlled next step.
The partnership sets out four areas of work:
These are valuable capabilities, but they exist at different maturity levels. The current commercial relationship is established; some automated workflows may already be used by Circle clients, while full native integration with Opus remains a future possibility. Buyer diligence should confirm exactly which steps are automated in a prospective deployment and which require human review or manual use of other systems.
Opus provides a specific example in which a behavioral health RCM team increased authorized days per review from approximately 3–5 to 7–10 after using Circle. That is operationally interesting because authorizations are directly connected to continuity of treatment and administrative workload.
If a team can secure clinically justified coverage for a longer appropriate period, it may need fewer repeated reviews, reduce disruption to care and stabilize reimbursement. But more authorized days are not automatically better in every circumstance. The amount of care must be clinically appropriate, supported by the record and consistent with applicable plan requirements.
The company has not disclosed how many cases were measured, whether payer or level-of-care mix changed, or whether the increase translated into lower denials or more posted cash. The reported result is a promising reference point, not a controlled study.
A second example describes a clinic analyzing a 500-plus-page payer prepayment audit in under 30 minutes. That demonstrates the potential to accelerate evidence review, but it does not establish that an appeal was won, a claim paid or a compliance issue resolved.
Opus links the partnership to rising regulatory and payer scrutiny of behavioral health access, parity and prior authorization. Its announcement cites recent federal and state actions related to authorization practices, denials and documentation standards.
That creates pressure from both directions. Providers must support care with accurate records and satisfy applicable medical-necessity and authorization requirements. Health plans face oversight of their own practices. An automated system that merely produces more convincing prose without grounding each assertion in actual treatment facts could create additional compliance risk.
For this category, AI should not be designed to manufacture justification. It should be able to distinguish clinical facts that appear in the chart from inference, identify missing assessments, flag contradictions and show exactly which payer criterion remains unaddressed. Relevant clinicians and compliance teams must retain decision-making responsibility.
The same evidence-tracing capability can be useful in payer audits: it helps explain what was known, when it was documented, which authorization rules applied and how a payment decision was reached.
Partnership economics may be as strategically important as the technology. Opus already works with organizations using its EHR, CRM and billing tools. Circle can use that existing distribution relationship to reach teams struggling with payer rules, continued-stay reviews and documentation gaps.
That route to market can be less disruptive than selling an entirely new system of record. A provider may not want to replace its EHR, but it may be willing to add a focused operating layer that improves authorizations or reduces the administrative cost of an audit.
For Opus, the partnership may increase the value of its existing platform without requiring it to build every specialized AI workflow in-house. For Circle, access to trusted workflow partners can lower onboarding friction and provide more relevant operational context.
Still, this is a strategic partnership, not an acquisition, funding round or proof of full product integration. Financial terms, any exclusivity and the scope of customer deployments were not disclosed.
Behavioral health organizations need to understand relationships among facility, level of care, payer contract, authorized days, completed treatment, documentation quality and realized reimbursement. Reporting each category independently makes it easy to miss the actual cause of a revenue gap.
A platform connecting those signals could make useful distinctions: an apparent underpayment may be caused by an incorrect contract rate, a missed authorization, a coverage limit, incomplete documentation, an unposted remittance or a genuine payer error.
Then it can direct the work to the right owner: utilization review, clinical documentation, billing, payer contracting or appeals. That is the beginning of a system that optimizes outcomes rather than simply producing reports.
The data-governance challenge is significant. Behavioral health information may carry additional confidentiality obligations, including special protections for certain substance use disorder treatment records. The partners will need to show that automated data access, record synthesis and communication are appropriately limited and audited in the environments where they are deployed.
The Opus–Circle partnership is a bet that revenue integrity in behavioral health begins inside the clinical record, not in an A/R queue.
The specific opportunity is to unify fragmented evidence, identify what a payer needs to authorize or reimburse treatment, and help a care organization resolve that gap without repeated manual reconstruction. If it works at scale, the result could be fewer interruptions, less staff rework and more dependable payment for appropriate care.
But buyers should separate an active sales partnership from completed technical integrations, and company-reported workflow examples from independently verified financial returns. The ability to analyze a 500-page audit quickly is impressive; the business case is whether the organization can make better, defensible decisions because of that analysis.
The long-term moat is not generating more appeals. It is knowing, continuously and accurately, what the care record supports, what the payer requires and what action will close the gap.
Independent coverage of behavioral health, payer policy, revenue integrity and automation.
Source: Opus and Circle Health, “Opus and Circle Health Unite to Protect Revenue and Strengthen Behavioral Health Operations,” October 15, 2026. Partnership scope and performance examples are company-reported. Strategic interpretation and diligence considerations are independent RCAI analysis.